Skip to main content
HR 4966 114th Congress House Health Administrative law and regulatory procedures Department of Health and Human Services Drug safety, medical device, and laboratory regulation Food and Drug Administration (FDA) Government information and archives Health technology, devices, supplies Infectious and parasitic diseases

Preventing Superbugs and Protecting Patients Act

Introduced: April 15, 2016 Introduced by: Lieu, Ted Democratic · California See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 22, 2016
Referred to the Subcommittee on Health.
Apr 15, 2016
Referred to the House Committee on Energy and Commerce.
Apr 15, 2016
Introduced in House
 Plain-English summary Congressional Research Service

Preventing Superbugs and Protecting Patients Act

This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to identify types of medical devices for which premarket notification must include proposed labeling, including validated instructions regarding cleaning, disinfection, and sterilization.

The FDA must issue final guidance regarding when a premarket notification is required for a modification to a medical device.
What's happening now April 22, 2016

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2
 Cosponsors 4
All 4 Democratic 4